Ocera Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 10   

Articles published

OCRX 8.48 -0.35 (-3.96%)
price chart
Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera ...
Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year.
Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech ...
Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year.
Related articles »  
Tobira Therapeutics Appoints Chairman Laurent Fischer, MD, Chief Executive ...
... Jennerex Inc. a private clinical-stage biotherapeutics company focused on cancer immunotherapy for liver cancer and other tumors which was acquired by SillaJen Inc. Prior as Founder and Chief Executive Officer of Ocera Therapeutics Inc. he licensed ...
Related articles »  
Morning Market Movers
Ocera Therapeutics (NASDAQ: OCRX) climbed 12.87% to $10.79 after the company announced a common stock offering. BofI Holding (NASDAQ: BOFI) shares climbed 10.12% to $80.87.
Related articles »  
Ocera Therapeutics Inc Announces New CFO
Tranzyme Pharma Announces Management Changes